This personalized approach could enhance treatment efficacy and reduce unnecessary toxicity; 3) Development of novel therapeutics: Our findings suggest that modulators of autophagy, particularly those targeting ATG4D, could represent a novel class of therapeutic agents for NPC. This evidence concerns the gene ATG4D and nasopharyngeal carcinoma.